Teva Pharmaceutical Industries, Takeda Pharmaceuticals USA and other defendants were slapped with an antitrust class action Thursday in Pennsylvania Eastern District Court. The suit, filed by Faruqi & Faruqi, Berger Montague and other law firms, accuses the defendants of conspiring to monopolize the market for the gout medication Colcrys. Counsel have not yet appeared for the defendants. The case is 2:21-cv-03500, Value Drug Company v. Takeda Pharmaceuticals, U.S.A., Inc. et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector.